CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Related Party	Preferred stock	Common stock	Common stock Related Party	Additional paid-in Capital	Additional paid-in Capital Related Party	Accumulated other comprehensive income (loss)	Accumulated deficit
Balance (in shares) at Dec. 31, 2022			2,369,797	18,102,523
Balance at Dec. 31, 2022	$ 197,389		$ 0	$ 2		$ 1,160,079		$ (32)	$ (962,660)
Increase (Decrease) in Stockholders' Equity
Issuance of common shares and sale of warrants in equity offerings, excluding to related parties, net of transaction costs (in shares)					180,551
Issuance of common shares and sale of warrants in equity offerings, excluding to related parties, net of transaction costs		$ 17,903					$ 17,903
Stock-based compensation expense related to equity-classified awards and Compensation expense related to stock options for services	11,250					11,250
Unrealized (loss) gain on marketable securities	(54)							(54)
Hercules warrant	544					544
Net loss	(76,896)								(76,896)
Balance (in shares) at Mar. 31, 2023			2,369,797	18,283,074
Balance at Mar. 31, 2023	150,136		$ 0	$ 2		1,189,776		(86)	(1,039,556)
Balance (in shares) at Dec. 31, 2022			2,369,797	18,102,523
Balance at Dec. 31, 2022	197,389		$ 0	$ 2		1,160,079		(32)	(962,660)
Increase (Decrease) in Stockholders' Equity
Unrealized (loss) gain on marketable securities	(10)
Net loss	(261,436)
Balance (in shares) at Sep. 30, 2023			2,369,797	18,494,192
Balance at Sep. 30, 2023	22,249		$ 0	$ 2		1,246,385		(42)	(1,224,096)
Balance (in shares) at Mar. 31, 2023			2,369,797	18,283,074
Balance at Mar. 31, 2023	150,136		$ 0	$ 2		1,189,776		(86)	(1,039,556)
Increase (Decrease) in Stockholders' Equity
Issuance of common shares and sale of warrants in equity offerings, excluding to related parties, net of transaction costs (in shares)				85,901	90,058
Issuance of common shares and sale of warrants in equity offerings, excluding to related parties, net of transaction costs	21,754	6,251				21,754	6,251
Stock-based compensation expense related to equity-classified awards and Compensation expense related to stock options for services	10,973					10,973
Unrealized (loss) gain on marketable securities	(3)							(3)
Hercules warrant	195					195
Net loss	(85,800)								(85,800)
Balance (in shares) at Jun. 30, 2023			2,369,797	18,459,033
Balance at Jun. 30, 2023	103,506		$ 0	$ 2		1,228,949		(89)	(1,125,356)
Increase (Decrease) in Stockholders' Equity
Issuance of common shares and sale of warrants in equity offerings, excluding to related parties, net of transaction costs (in shares)				12,200	22,959
Issuance of common shares and sale of warrants in equity offerings, excluding to related parties, net of transaction costs	2,731	1,924				2,731	1,924
Stock-based compensation expense related to equity-classified awards and Compensation expense related to stock options for services	12,660					12,660
Unrealized (loss) gain on marketable securities	47							47
Hercules warrant	121					121
Net loss	(98,740)								(98,740)
Balance (in shares) at Sep. 30, 2023			2,369,797	18,494,192
Balance at Sep. 30, 2023	$ 22,249		$ 0	$ 2		1,246,385		(42)	(1,224,096)
Balance (in shares) at Dec. 31, 2023	19,875,427		2,369,797	19,875,427
Balance at Dec. 31, 2023	$ 405,333		$ 0	$ 2		1,741,153		468	(1,336,290)
Increase (Decrease) in Stockholders' Equity
Issuance of common shares and sale of warrants in equity offerings, excluding to related parties, net of transaction costs (in shares)				750,000	59,236
Issuance of common shares and sale of warrants in equity offerings, excluding to related parties, net of transaction costs	311,560	262,145				311,560	262,145
Stock-based compensation expense related to equity-classified awards and Compensation expense related to stock options for services	19,902					19,902
Unrealized (loss) gain on marketable securities	(640)							(640)
Net loss	(147,541)								(147,541)
Balance (in shares) at Mar. 31, 2024			2,369,797	20,684,663
Balance at Mar. 31, 2024	$ 850,759		$ 0	$ 2		2,334,760		(172)	(1,483,831)
Balance (in shares) at Dec. 31, 2023	19,875,427		2,369,797	19,875,427
Balance at Dec. 31, 2023	$ 405,333		$ 0	$ 2		1,741,153		468	(1,336,290)
Increase (Decrease) in Stockholders' Equity
Unrealized (loss) gain on marketable securities	803
Net loss	$ (406,476)
Balance (in shares) at Sep. 30, 2024	21,806,436		2,369,797	21,806,436
Balance at Sep. 30, 2024	$ 777,155		$ 0	$ 2		2,518,648		1,271	(1,742,766)
Balance (in shares) at Mar. 31, 2024			2,369,797	20,684,663
Balance at Mar. 31, 2024	850,759		$ 0	$ 2		2,334,760		(172)	(1,483,831)
Increase (Decrease) in Stockholders' Equity
Issuance of common shares and sale of warrants in equity offerings, excluding to related parties, net of transaction costs (in shares)				346,153	670,077
Issuance of common shares and sale of warrants in equity offerings, excluding to related parties, net of transaction costs	85,950	48,174				85,950	48,174
Stock-based compensation expense related to equity-classified awards and Compensation expense related to stock options for services	24,404					24,404
Unrealized (loss) gain on marketable securities	(196)							(196)
Net loss	(151,971)								(151,971)
Balance (in shares) at Jun. 30, 2024			2,369,797	21,700,893
Balance at Jun. 30, 2024	857,120		$ 0	$ 2		2,493,288		(368)	(1,635,802)
Increase (Decrease) in Stockholders' Equity
Issuance of common shares and sale of warrants in equity offerings, excluding to related parties, net of transaction costs (in shares)					105,543
Issuance of common shares and sale of warrants in equity offerings, excluding to related parties, net of transaction costs		$ 7,462					$ 7,462
Stock-based compensation expense related to equity-classified awards and Compensation expense related to stock options for services	17,898					17,898
Unrealized (loss) gain on marketable securities	1,639							1,639
Net loss	$ (106,964)								(106,964)
Balance (in shares) at Sep. 30, 2024	21,806,436		2,369,797	21,806,436
Balance at Sep. 30, 2024	$ 777,155		$ 0	$ 2		$ 2,518,648		$ 1,271	$ (1,742,766)